# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA3492614 | DDD01300371 | pIC50 | < | 4 | ALA4649946 | nM | Leishmania donovani (strain BPK282A1) | ||||
2. | ALA3492614 | DDD01300371 | pIC50 | < | 4 | ALA4649946 | nM | Leishmania donovani (strain BPK282A1) | ||||
3. | ALA3492614 | DDD01300371 | pIC50 | < | 4 | ALA4649971 | nM | Mycobacterium tuberculosis | ||||
4. | ALA3492614 | DDD01300371 | Percent Effect | = | -18.523 | % | ALA4649971 | % | Mycobacterium tuberculosis | |||
5. | ALA3492614 | DDD01300371 | Percent Effect | = | 9.649 | % | ALA4649962 | % | Leishmania infantum | |||
6. | ALA3492614 | DDD01300371 | Percent Effect | = | -48.808 | % | ALA4649964 | % | Plasmodium falciparum | |||
7. | ALA3492614 | DDD01300371 | INHIBITION | = | 1.21 | % | ALA4513221 | % | Plasmodium falciparum | |||
8. | ALA3492614 | DDD01300371 | INHIBITION | = | -42.9 | % | ALA4513220 | % | Plasmodium falciparum | |||
9. | ALA3492614 | DDD01300371 | INHIBITION | = | -20.6 | % | ALA4513219 | % | Homo sapiens | |||
10. | ALA3492614 | DDD01300371 | Percent Effect | = | -13.643 | % | ALA4649965 | % | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | |||
11. | ALA3492614 | DDD01300371 | Percent Effect | = | -6.024 | % | ALA4649942 | % | Leishmania donovani | |||
12. | ALA3492614 | DDD01300371 | Percent Effect | = | -27.56 | % | ALA4649972 | % | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | |||
13. | ALA3492614 | DDD01300371 | Percent Effect | = | 1.574 | % | ALA4649943 | % | Plasmodium falciparum (isolate 3D7) | |||
14. | ALA3492614 | DDD01300371 | Percent Effect | = | 8.43 | % | ALA4649954 | % | Trypanosoma cruzi (strain CL Brener) | |||
15. | ALA3492614 | DDD01300371 | Percent Effect | = | -6.84 | % | ALA4649949 | % | ||||
16. | ALA3492614 | DDD01300371 | Percent Effect | = | 0.451 | % | ALA4649945 | % | Plasmodium falciparum | |||
17. | ALA3492614 | DDD01300371 | Percent Effect | = | -23.139 | % | ALA4649948 | % | ||||
18. | ALA3492614 | DDD01300371 | Inhibition | = | 0.155 | % | ALA3507681 | % | ||||
19. | ALA3492614 | DDD01300371 | Inhibition | = | 22.393 | % | ALA3988443 | % | Leishmania donovani (strain BPK282A1) | |||
20. | ALA3492614 | DDD01300371 | Percent Effect | = | -10.028 | % | ALA4649957 | % | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) |